IRCT2015020120895N1 IRCT 2015-11-08 Bandare-abbas University of Medical Sciences Evaluating the effect of an herbal complement on sex hormones in infertile men The effect of Herbal composition on sex hormones level: a Single-blinded, comparative controlled clinical trial 2015-01-31 anticipated 62 Complete https://irct.ir/trial/18450 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: A simple randomization is provided with a sealed envelope. In this method, a number of cards selected by the researcher as the intervention group and the same number of cards for the control group are considered; Then, by merging the cards together (flipping the cards), a card is taken out and its allocation is recorded, and that card is returned to the other cards after being taken out. The cards are then merged again and another card is removed. This process continues until a random sequence is reached according to the sample size, Blinding description: The data collector who evaluates the outcome has no information about the coded packets and their contents and does not know what kind of intervention the intervention group and the control group will receive. 3 Male infertility. Intervention 1: The intervention group, besides a standard treatment prescribed by an urologist, received two 500 mg capsules containing 350 mg of pollen essence powder and 250 grams of black seed powder every morning and night for three months. Within 90 days, every patient received 180 capsules in sealed coded envelopes. The herbal composition capsules were manufactured by the Golbadistan Company. Intervention 2: The control group received 180 capsules of placebo(500 mg) in the same shape and color as the medicine used in the intervention group besides the standard treatment for 3 months. The placebo was manufactured by Golbadistan Company. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is As the present clinical trial is currently patented as a new invention, and now the whole process of commercialization is being completed. Thus in near future we may publish the findings.